Hypothesis:
Phosphorus and vitamin D (calcitriol) supplementation in the Phex
mouse, a murine model for endolymphatic hydrops (ELH), will improve otic
capsule mineralization and secondarily ameliorate the postnatal development
of ELH and sensorineural hearing loss (SNHL). Background: Male Phex mice
have X-linked hypophosphatemic rickets (XLH), which includes osteomalacia of
the otic capsule. The treatment for XLH is supplementation with phosphorus
and calcitriol. The effect of this treatment has never been studied on otic
capsule bone and it is unclear if improving the otic capsule bone could
impact the mice’s postnatal development of ELH and SNHL.
Methods:
Four cohortswere studied: 1) wild-type control, 2) Phex control, 3)
Phex prevention, and 4) Phex rescue. The control groups were not given any
dietary supplementation. The Phex prevention group was supplemented with
phosphorus added to its drinking water and intraperitoneal calcitriol
frompostnatal day (P) 7–P40. The Phex rescue group was also
supplemented with phosphorus and calcium but only from P20 to P40. At P40,
all mice underwent auditory brainstem response (ABR) testing, serum
analysis, and temporal bone histologic analysis. Primary outcome was otic
capsule mineralization. Secondary outcomes were degree of SNHL and presence
ELH.
Results:
Both treatment groups had markedly improved otic capsule
mineralization with less osteoid deposition. The improved otic capsule
mineralized did not prevent the development of ELH or SNHL.
Conclusion:
Supplementation with phosphorus and calcitriol improves otic capsule
bone morphology in the Phex male mouse but does not alter development of ELH
or SNHL.